CSS
ALT icon

Cubist Systematic Strategies’s Altimmune ALT Stock Holding History

Cubist Systematic Strategies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,830
Closed -$232K – 2916
2024
Q1 		$232K Sell
22,830
-122,155
-84% -$1.24M ﹤0.01% 3011
2023
Q4 		$1.63M Buy
144,985
+98,832
+214% +$413K 0.01% 1674
2023
Q3 		$120K Sell
46,153
-102,249
-69% -$293K ﹤0.01% 2907
2023
Q2 		$524K Buy
148,402
+48,934
+49% +$220K ﹤0.01% 2367
2023
Q1 		$420K Buy
+99,468
New +$1.18M ﹤0.01% 2786
2022
Q4 		– Sell
-170,947
Closed -$2.18M – 4212
2022
Q3 		$2.18M Buy
170,947
+71,582
+72% +$1.06M 0.01% 1918
2022
Q2 		$1.16M Buy
99,365
+9,880
+11% +$60.9K 0.01% 2353
2022
Q1 		$545K Sell
89,485
-1,906
-2% -$14K ﹤0.01% 2486
2021
Q4 		$837K Buy
+91,391
New +$971K 0.01% 2052
2021
Q3 		– Sell
-69,300
Closed -$683K – 2942
2021
Q2 		$683K Sell
69,300
-60,917
-47% -$833K 0.01% 1803
2021
Q1 		$1.84M Buy
130,217
+56,117
+76% +$907K 0.02% 1093
2020
Q4 		$836K Buy
74,100
+618
+0.8% +$7.28K 0.01% 1494
2020
Q3 		$970K Buy
+73,482
New +$1.47M 0.01% 1354
2017
Q1 		– Sell
-104
Closed -$102K – 1611
2016
Q4 		$102K Buy
+104
New +$93.2K 0.01% 1478

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's ALT Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Altimmune (ALT) in Q2 2024, closing a stake of 22,830 shares — an estimated $232K sold.

Cubist Systematic Strategies first reported a position in ALT in Q4 2016 and held it in 14 quarters. The position peaked at $2.18M in Q3 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,830 Altimmune shares in Q2 2024, an estimated $232K.
  • Cubist Systematic Strategies first reported a position in Altimmune in Q4 2016 and held it in 14 quarters.
  • Cubist Systematic Strategies's Altimmune position peaked at $2.18M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.